Equity analyst research on UK stocks from DirectorsTalk

Five UK Stocks to Watch in 2024
[shareaholic app="share_buttons" id_name="post_below_content"]

DirectorsTalk brings you professional opinions from leading equity research analysts on companies listed on the London Stock Exchange. This article contains a small selection of five stocks in the clean energy, financial services and telecommunications sectors. Equity analyst research across all sectors is available here. DirectorsTalk aims to help investors make more informed investment decisions.

Quadrise plc (LON:QED) produce transition fuels called MSAR® (pronounced ‘em-sar’) and bioMSAR™, which allow clients in the shipping, utilities and industrial sectors to reduce carbon emissions whilst also saving costs.

Arbuthnot Banking Group PLC (LON:ARBB), trading as Arbuthnot Latham, provides private and commercial banking products and services in the United Kingdom.

TEAM plc (LON:TEAM) is building a wealth, asset management and complementary financial services group. 

Cerillion plc (LON:CER) is a leading provider of billing, charging and customer management systems with more than 20 years’ experience delivering its solutions across a broad range of industries including the telecommunications, finance, utilities and transportation sectors.

Tern PLC (LON:TERN) is an AIM-listed provider of venture capital to exciting IoT innovators seeking scale and market share.

Share on:
Find more news, interviews, share price & company profile here for:

Why AI flexibility now depends on architecture not algorithms

The future of AI in enterprise won’t be won by picking the best model, it’ll be won by building systems that can switch between them.

Pharma faces a strategic turning point in AI adoption

AI in pharma is moving from operational support to strategic driver as companies prioritise messaging that delivers measurable prescriber impact.

Business resilience stands to shift as fraud accountability gains sharp legal focus

Fraud risk has moved into the boardroom and onto the investor radar, with legal consequences that now demand a new level of corporate discipline.

Seasonal trends face a more sceptical market

Seasonal trends face new scrutiny as investors weigh valuation risk, policy shifts and sector rotation in a more complex year-end environment.

Tern Plc updates position in Talking Medicines with new convertible loan notes

Tern Plc has received about £230,000 in new unsecured convertible loan notes from Talking Medicines after cancelling around £180,000 of short term loans provided over 2024 and 2025.

The real problem holding back connected vehicle programmes

Vehicle identity is fast becoming a core infrastructure challenge, and a new bottleneck for OEMs aiming to scale software-defined platforms.

Search

Search